HSC-based in vitro experiments demonstrated that LS could inhibit the cell viability, promote the cell apoptosis, decrease the expression of liver fibrosis markers, as well as downregulate the JAK1/STAT3 signaling pathway. The gene discussed is STAT3; the disease is Hepatic fibrosis.